Starling Oncology (STLNW) Cash from Operations (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 639.05% |
| Mar 31, 2026 | -168.51% |
| Dec 31, 2025 | 125.60% |
| Sep 30, 2025 | -23.80% |
| Jun 30, 2025 | -104.53% |
| Mar 31, 2025 | -224.70% |
| Dec 31, 2024 | 388.40% |
| Sep 30, 2024 | 105.23% |
| Jun 30, 2024 | 1.40% |
| Mar 31, 2024 | -307.99% |
| Dec 31, 2023 | 53.15% |
| Sep 30, 2023 | 4.04% |
| Jun 30, 2023 | 43.96% |
| Mar 31, 2023 | -10.40% |
| Dec 31, 2022 | 31.38% |
| Sep 30, 2022 | -96.54% |
| Jun 30, 2022 | 38.88% |
| Mar 31, 2022 | 27.23% |
| Dec 31, 2021 | -771.03% |
| Sep 30, 2021 | 62.43% |